PRECLINICAL STUDY OF NEW NANOPARTICLES WITH ANTICANCER AND MRI FUNCTIONS

被引:0
|
作者
Lee, J. W.
Lee, J. I.
Lee, D. H. [1 ]
Kim, Y. S. [1 ]
Hong, S. -S. [1 ]
Maeng, J. -H. [1 ]
Jung, K. -H. [1 ]
机构
[1] Inha Univ, Sch Med, Inchon, South Korea
关键词
D O I
10.1016/S0168-8278(10)60880-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S342 / S343
页数:2
相关论文
共 50 条
  • [22] Preclinical toxicology (subacute and acute) and efficacy of a new squalenoyl gemcitabine anticancer nanomedicine
    Reddy, L. Harivardhan
    Marque, Pierre-Emmanuel
    Dubernet, Catherine
    Mouelhi, Sinda-Lepetre
    Desmaele, Didier
    Couvreur, Patrick
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2008, 325 (02): : 484 - 490
  • [23] Anticancer effect of bisphosphonates: new insights from clinical trials and preclinical evidence
    Daniele, Gennaro
    Giordano, Pasqualina
    De Luca, Antonella
    Piccirillo, Maria Carmela
    Di Maio, Massimo
    Del Giudice, Antonia
    De Feo, Gianfranco
    Bryce, Jane
    Lamura, Luana
    Vecchione, Aldo
    Normanno, Nicola
    Perrone, Francesco
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (02) : 299 - 307
  • [24] SUPERPARAMAGNETIC NANOPARTICLES AS BLOOD-POOL CONTRAST AGENTS - CONTRIBUTION TO MRI PRECLINICAL INVESTIGATIONS
    BENDERBOUS, S
    BONNEMAIN, B
    RADIOLOGE, 1995, 35 (11): : S248 - S252
  • [25] Elucidating brain water management in hypertension: a preclinical MRI study
    Naessens, D. M. P.
    Coolen, B. F.
    de Vos, J.
    VanBavel, E.
    Strijkers, G. J.
    Bakker, E. N. T. P.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2019, 39 : 504 - 505
  • [26] PRECLINICAL EVALUATION OF ILLUDINS AS ANTICANCER AGENTS
    KELNER, MJ
    MCMORRIS, TC
    BECK, WT
    ZAMORA, JM
    TAETLE, R
    CANCER RESEARCH, 1987, 47 (12) : 3186 - 3189
  • [27] Anticancer Potential of Biogenic Silver Nanoparticles: A Mechanistic Study
    Khan, Mohd Shahnawaz
    Alomari, Alya
    Tabrez, Shams
    Hassan, Iftekhar
    Wahab, Rizwan
    Bhat, Sheraz Ahmad
    Alafaleq, Nouf Omar
    Altwaijry, Nojood
    Shaik, Gouse M.
    Zaidi, Syed Kashif
    Nouh, Wessam
    Alokail, Majed S.
    Ismael, Mohamed A.
    PHARMACEUTICS, 2021, 13 (05)
  • [28] New method for quantification of intratumoral heterogeneity: a feasibility study on Ktrans maps from preclinical DCE-MRI
    Charly Girot
    Andreas Volk
    Christine Walczak
    Nathalie Lassau
    Stéphanie Pitre-Champagnat
    Magnetic Resonance Materials in Physics, Biology and Medicine, 2021, 34 : 845 - 857
  • [29] New method for quantification of intratumoral heterogeneity: a feasibility study on Ktrans maps from preclinical DCE-MRI
    Girot, Charly
    Volk, Andreas
    Walczak, Christine
    Lassau, Nathalie
    Pitre-Champagnat, Stephanie
    MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE, 2021, 34 (06) : 845 - 857
  • [30] Progress in preclinical and clinical studies for the development of new anticancer drugs in Japan, with emphasis on taxanes
    Saijo, N
    Nishio, K
    Ohta, S
    Arioka, H
    Funayama, Y
    Fukuoka, K
    Kurokawa, H
    Nomoto, T
    Ishida, T
    Yamamoto, N
    Tamura, T
    Shinkai, T
    Eguchi, K
    Ohe, Y
    Kunito, H
    Ohtsu, T
    Sasaki, Y
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 38 : S11 - S15